James E. Flynn - Possible Member of 10% Group, 10%+ Owner at Xilio Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Possible Member of 10% Group, 10%+ Owner
Issuer Symbol
XLO on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by James E. Flynn since 06 Mar 2025

Holdings reported by James E. Flynn for Xilio Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 1,143,972 $949,497 $0.8300 26 Oct 2021 Through Deerfield Partners, L.P.
Common Stock 1,143,972 $949,497 $0.8300 26 Oct 2021 Through Deerfield Private Design Fund V, L.P.
Series C Preferred Stock 0 26 Oct 2021 Through Deerfield Partners, L.P. Common Stock
Series C Preferred Stock 0 26 Oct 2021 Through Deerfield Private Design Fund V, L.P. Common Stock

Transactions reported by James E. Flynn for Xilio Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.